Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Falcon Photonics is a medical technology company focused on the development of high-sensitivity photonic integrated circuits (PICs) for diagnostic and life science applications. The company utilizes proprietary whispering gallery mode (WGM) resonator technology to enable label-free, real-time detection of biological analytes with laboratory-grade precision. Their primary focus has been the creation of a portable, low-cost biosensor platform capable of rapid pathogen detection, including a specific application for SARS-CoV-2. By integrating complex optical systems onto a single chip, Falcon Photonics aims to revolutionize point-of-care diagnostics and environmental monitoring. The technology is designed to be highly scalable, offering a path toward mass-produced, disposable diagnostic chips for a variety of healthcare settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Falcon Photonics.